Asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (All of the following criteria) 1. Age 18-50 yr; 2. Doctors diagnosis of asthma; 3. Patients who need inhaled corticosteroids as controller medication (step 2-4 GINA guideline) and / or montelukast; 4. Inhaled corticosteroids ≥ 3 months in the previous year; 5. Access to the internet; 6. Written informed consent.
Exclusion criteria
Exclusion criteria: 1. Inability to understand written and oral Dutch instructions; 2. Active diseases likely to interfere with the purpose of the study, such as a terminal illness or a severe psychiatric disease; 3. Daily or alternate day oral corticosteroid therapy for at least 1 month before entering the study; 4. Patients who are primarily under treatment by a pulmonologist.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Patient participation in IBSM; 2. Patients with a clinically relevant improvement in asthma-related quality of life. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient level: 1. Effect evaluation: A. Clinical outcome; B. Self-management related outcome. Professional and organizational level: 1. General practice participation in IBSM; 2. Process evaluation: A. Adherence of practice nurses/ GP’s to the implementation strategy; B. Experience with IBSM; C. Feasibility of IBSM in daily practice. 3. Economic evaluation: A. Cost-effectiveness; B. Cost-utility. | — |
Contacts
Leiden University Medical Center, Dept of Medical Decision Making P.O. Box 9600